Descripción de negocio
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Consejo de gestión & Consejo de supervisión
| CEO |
| Paul Hudson |
| Consejo de gestión |
| François-Xavier Roger, Houman Ashrafian, Natalie Bickford, Olivier Charmeil, Brian Foard, Emmanuel Frenehard, Brendan O’Callaghan, Roy Papatheodorou, Madeleine Roach, Thomas Triomphe, Julie Van Ongevalle |
| Consejo de supervisión |
| Frédéric Oudéa, Paul Hudson, Christophe Babule, Clotilde Delbos, Rachel Duan, Carole Ferrand, Lise Kingo, Patrick Kron, Wolfgang Laux, Barbara Lavernos, Fabienne Lecorvaisier, Anne-Françoise Nesmes, Gilles Schnepp, John Sundy, Ceng-Yann Tran, Emile Voest, Antoine Yver |
Datos de la empresa
| Nombre: |
Sanofi S.A. |
| Dirección: |
54, Rue La Boétie,F-75008 Paris |
| Teléfono: |
+33-1-53-77-40-00 |
| Fax: |
+33-1-53-77-43-03 |
| E-mail: |
-
|
| Internet: |
https://www.sanofi.com/ |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
88.70% |
| Fecha de OPI: |
- |